利索-全球专利检索

  1. 登录
  2. 注册

搜索结果

94 条记录 (耗时 0.052 秒)

    3-heteroarylmethyl-imidazo[1,2-b]pyridazin-6-yl derivatives
    1.
    发明授权
    3-heteroarylmethyl-imidazo[1,2-b]pyridazin-6-yl derivatives 有权
    3-杂芳基甲基 - 咪唑并[1,2-b]哒嗪-6-基衍生物

    公开(公告)号：US08389526B2

    公开(公告)日：2013-03-05

    申请号：US12849642

    申请日：2010-08-03

    申请人： Pascal Furet ,  Clive McCarthy ,  Joseph Schoepfer ,  Stefan Stutz

    发明人： Pascal Furet ,  Clive McCarthy ,  Joseph Schoepfer ,  Stefan Stutz

    IPC分类号： A01N43/58 ,  A61K31/50 ,  C07D487/00

    CPC分类号： C07D487/04

    摘要： The invention relates to compounds of formula (I) and salts thereof wherein the substituents are as defined in the specification, the application of a compound of formula (I) in a process for the treatment of the human or animal body, in particular with regard to C-Met tyrosine kinase mediated disease; the use of a compound of formula (I) for manufacturing a medicament for the treatment of such diseases; pharmaceutical compositions comprising a compound of the formula (I), optionally in the presence of a combination partner; processes for the preparation of a compound of formula (I).

    摘要翻译： 本发明涉及式（I）化合物及其盐，其中取代基如本说明书中所定义，式（I）化合物在治疗人或动物体的方法中的应用，特别是关于 对C-Met酪氨酸激酶介导的疾病; 使用式（I）化合物制备用于治疗这些疾病的药物; 包含式（I）化合物的药物组合物，任选地在组合配偶体存在下; 制备式（I）化合物的方法。

    3-HETEROARYLMETHYL-IMIDAZO[1,2-B]PYRIDAZIN-6-YL DERIVATIVES
    2.
    发明申请
    3-HETEROARYLMETHYL-IMIDAZO[1,2-B]PYRIDAZIN-6-YL DERIVATIVES 有权
    3-异丙基甲基咪唑并[1,2-B]吡啶-6-基衍生物

    公开(公告)号：US20110039831A1

    公开(公告)日：2011-02-17

    申请号：US12849642

    申请日：2010-08-03

    申请人： Pascal Furet ,  Clive McCarthy ,  Joseph Schoepfer ,  Stefan Stutz

    发明人： Pascal Furet ,  Clive McCarthy ,  Joseph Schoepfer ,  Stefan Stutz

    IPC分类号： A61K31/5025 ,  C07D487/04 ,  A61K31/551 ,  A61P35/00

    CPC分类号： C07D487/04

    摘要： The invention relates to compounds of formula (I) and salts thereof wherein the substituents are as defined in the specification, the application of a compound of formula (I) in a process for the treatment of the human or animal body, in particular with regard to C-Met tyrosine kinase mediated disease; the use of a compound of formula (I) for manufacturing a medicament for the treatment of such diseases; pharmaceutical compositions comprising a compound of the formula (I), optionally in the presence of a combination partner; processes for the preparation of a compound of formula (I).

    摘要翻译： 本发明涉及式（I）化合物及其盐，其中取代基如本说明书中所定义，式（I）化合物在治疗人或动物体的方法中的应用，特别是关于 对C-Met酪氨酸激酶介导的疾病; 使用式（I）化合物制备用于治疗这些疾病的药物; 包含式（I）化合物的药物组合物，任选地在组合配偶体存在下; 制备式（I）化合物的方法。